Replies to post #83100 on Biotech Values

[mcbio]

Re: Phase 2 stat sig

Achieving stat sig (95%)for a P II trial is asking for a lot IMO especially since most p II trials normally have small patient samples, and patients are given a variety of doses. In this case the sample size is only 34. If you were to read a similar title for a P III trial then what you say is absolutely true.

I understand your point and it's well taken. But, we do still see a lot of Phase 2 trial results that do attain statistical significance and, all things being equal, I'd much rather back a drug that has attained statistical significance in a Phase 2 than one that has not.